Table 2.
Assessments | Base-line | 1 weeks | 2 weeks | 3 weeks | 6 weeks | 3 Month | 6 Month | 12 Month | 15 Month | 18 Month | 21 Month | 24 Month |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical assessment | ||||||||||||
Socio-demographic characteristics | √ | |||||||||||
Psychological characteristics | ||||||||||||
Personality | √ | √ | √ | |||||||||
Social support | √ | √ | √ | √ | ||||||||
Stress-related status | √ | √ | √ | √ | ||||||||
Outcomes of depression | ||||||||||||
Depressive symptom | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
Functional disability | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
Suicidality | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
Quality of life | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
Biological assessment | ||||||||||||
Blood biomarker | √ | √ | ||||||||||
Salivary cortisol (cortisol study only) | √ | √ | √ | √ | √ | |||||||
Electrocardiography | √ | √ | ||||||||||
Resting BP, body mass index | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | ||
Treatment related assessment | ||||||||||||
Antidepressants, dosage, duration | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
Adverse events | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
Withdrawal | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ | √ |
MAKE BETTER: MAKE Biomarker discovery for Enhancing anTidepressants Treatment Effect and Response, BP: blood pressure